Pharmacologic Management of Human Immunodeficiency Virus and Common Chronic Conditions

被引：1

作者：

Pitts, Courtney J. ^{[1
]}

Anthamatten, Angelina ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA

来源：

JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 03期

关键词：

antiretroviral therapy; diabetes; drug interactions; dyslipidemia; HIV; hypertension; HIV;

D O I：

10.1016/j.nurpra.2019.10.024

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

There has been an evolution in the care and survival of people living with human immunodeficiency virus (PLWH) and AIDS. Increased survival of PLWH is attributed to antiretroviral therapy. However, adverse effects of antiretroviral therapy increase the likelihood that PLWH may also be diagnosed with chronic conditions such as diabetes mellitus, hypertension, and dyslipidemia. Drug-drug interactions are common when coadministering human immunodeficiency virus drugs and therapies for common chronic conditions managed in primary care. To prevent adverse events, nurse practitioners should know about these interactions before prescribing new regimens or modifying a regimen. (C) 2019 Elsevier Inc. All rights reserved.

引用

页码：167 / 171

页数：5